NCT04819516View on ClinicalTrials.gov

Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Colorectal Cancer
Interventions
PROCEDURE

high-intensity focused ultrasound therapy

Patients will receive high-intensity focused ultrasound therapy in local site.

DRUG

Toripalimab

Toripalimab plus regorafenib

Trial Locations (1)

310000

RECRUITING

the Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER